์ฃผ์š” ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ

๊ท€ํ•˜์˜ ๋ธŒ๋ผ์šฐ์ €๊ฐ€ ์™„๋ฒฝํ•˜๊ฒŒ ์ง€์›๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์˜ต์…˜์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์ตœ์‹  ๋ฒ„์ „์œผ๋กœ ์—…๊ทธ๋ ˆ์ด๋“œํ•˜๊ฑฐ๋‚˜ Mozilla Firefox, Microsoft Edge, Google Chrome ๋˜๋Š” Safari 14 ์ด์ƒ์„ ์‚ฌ์šฉํ•˜์„ธ์š”. ๊ฐ€๋Šฅํ•˜์ง€ ์•Š๊ฑฐ๋‚˜ ์ง€์›์ด ํ•„์š”ํ•œ ๊ฒฝ์šฐ ํ”ผ๋“œ๋ฐฑ์„ ๋ณด๋‚ด์ฃผ์„ธ์š”.

Elsevier
์—˜์Šค๋น„์–ด์™€ ํ•จ๊ป˜ ์ถœํŒ

ํ”„๋กœํ•„

Leslie Thompson

Leslie Thompson

University of California, Irvine, USA

Leslie M. Thompson, PhD, is a Bren Professor in the Departments of Psychiatry and Human Behavior and Neurobiology and Behavior and Co-Director of the Sue and Bill Gross Stem Cell Research Center at the UC Irvine. She was a member of the international consortium that identified the Huntingtonโ€™s disease (HD) gene in 1993. Her laboratory investigates RNA, molecular, and cellular mechanisms by which expanded CAG repeats drive neurodegeneration, with the goal of developing disease-modifying therapies, including gene- and cell-based approaches. She also studies XDP and ALSr. Thompson is an AAAS Fellow, founding Coโ€“Editor-in-Chief of the Journal of Huntingtonโ€™s Disease, Chair of the Huntingtonโ€™s Disease Foundation SAB and a member of the Johns Hopkins Packard Center for ALS SAB.